Biologically Active Small Molecules, LKT Labs, 606143-89-9, NEW! Life Science

HomeAll Products

NEW! Life Science 606143-89-9 LKT Labs Biologically Active Small Molecules

1 - 1 of 1
Sort
View
Show
  • LKT Labs

    ARRY-162 is an orally bioavailable noncompetitive inhibitor of MEK1/2 and ERK that shows anticancer chemotherapeutic activity. Inhibition of MEK inhibits downstream signaling by IL-1, IL-6, and TNF. ARRY-162 inhibits proliferation in melanoma, non-small-cell lung cancer (NSCLC), head/neck cancer,…